23945-84-8 Usage
Uses
Used in Pharmaceutical Industry:
6-chloro-5-nitronicotinoyl chloride is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to form a wide range of chemical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
6-chloro-5-nitronicotinoyl chloride is used as a building block in the production of agrochemicals, such as pesticides and herbicides, due to its reactivity and ability to form stable compounds. This contributes to the development of more effective and environmentally friendly agrochemicals.
Used in Organic Synthesis:
6-chloro-5-nitronicotinoyl chloride is used as a versatile reagent in organic synthesis for its ability to participate in various chemical reactions, such as nucleophilic substitution, electrophilic substitution, and condensation reactions. This allows for the creation of a diverse range of organic compounds with potential applications in various industries.
Used in Material Science:
6-chloro-5-nitronicotinoyl chloride is used as a precursor in the development of new materials with unique properties, such as high thermal stability, chemical resistance, and specific optical or electronic characteristics. This contributes to the advancement of material science and the creation of innovative materials for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 23945-84-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,9,4 and 5 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 23945-84:
(7*2)+(6*3)+(5*9)+(4*4)+(3*5)+(2*8)+(1*4)=128
128 % 10 = 8
So 23945-84-8 is a valid CAS Registry Number.
23945-84-8Relevant academic research and scientific papers
THE NITROPYRIDINYL ETHYLENEIMINE COMPOUND, THE PHARMACEUTICAL COMPOSITION CONTAINING IT, THE PREPARATION METHOD AND USE THEREOF
-
, (2011/10/10)
The present invention discloses a nitropyridinyl ethyleneimine compound as shown in the formula I and a preparation method of the same, as well as use of the compound in manufacture of a prodrug and in manufacture of a drug for treating a tumor.
Novel indanyl-substituted imidazo[1,2-a]pyridines as potent reversible inhibitors of the gastric H+/K+-ATPase
Zimmermann, Peter Jan,Buhr, Wilm,Brehm, Christof,Palmer, Andreas Marc,Feth, Martin Philipp,Senn-Bilfinger, Joerg,Simon, Wolfgang-Alexander
, p. 5374 - 5378 (2008/09/21)
A series of novel 8-indanylamino- and 8-indanyloxy-substituted imidazo[1,2-a]pyridines with reduced lipophilicity was synthesized from easily accessible starting compounds. The anti-secretory activity of these compounds has been assessed in a competitive
TETRAHYDROQUINOXALINES AND THEIR USE AS M2 ACETYLCHOLINE RECEPTOR AGONISTS
-
Page/Page column 44-45, (2008/06/13)
The invention relates to tetrahydroquinoxalines of formula (I), in which A, X, R1, R2, R3, R4, and R are defined as cited in claim 1, to a method for their production and to the use thereof for producing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular diseases.
